Following encouraging research findings , retatrutide, a novel peptide therapy for treating type 2 diabetes , has received regulatory approval from Great Britain's Drug and Regulatory Agency ( MHRA https://hannapusy575600.blogpayz.com/41535318/retatrutide-treatment-peptide-british-green-light-and-access